Tenaya Therapeutics, Inc. (TNYA): Shareholders' Equity
$123.27M
As of 2025-12-31
$69.41M
As of 2026-06-30
-20.3%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $123.27M | +32.8% | 2026-03-11, Balance as of period end |
| 2024-12-31 | $92.85M | -33.4% | 2026-03-11, Balance as of period end |
| 2023-12-31 | $139.42M | -42.7% | 2025-03-10, Balance as of period end |
| 2022-12-31 | $243.38M | -12.6% | 2024-03-18, Balance as of period end |
| 2021-12-31 | $278.53M | n/m | 2023-03-08, Balance as of period end |
| 2020-12-31 | -$81.31M | n/a | 2022-03-23, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Tenaya Therapeutics, Inc. (TNYA) | 2025-12-31 | $123.27M | +32.8% |
| Inhibrx Biosciences, Inc. (INBX) | 2025-12-31 | $7.99M | -94.0% |
| Black Diamond Therapeutics, Inc. (BDTX) | 2025-12-31 | $112.21M | +34.7% |
| ImageneBio, Inc. (IMA) | 2025-12-31 | $133.14M | n/m |
| Precision Biosciences Inc (DTIL) | 2025-12-31 | $92.25M | +63.6% |
| Compugen Ltd (CGEN) | 2025-12-31 | $102.73M | +87.1% |
| Palisade Bio, Inc. (PALI) | 2025-12-31 | $129.38M | n/m |
| Artiva Biotherapeutics, Inc. (ARTV) | 2025-12-31 | $109.97M | -41.1% |
| Cabaletta Bio, Inc. (CABA) | 2025-12-31 | $112.05M | -26.4% |
Compare TNYA, INBX, BDTX, IMA side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗